You are here:

Post-graduate Courses & Workshops

Published on


The 52nd Union World Conference on Lung Health hosts a number of interesting post-graduate courses and workshops that are open to all (one does not need to register for the conference to attend these courses or workshops). Please do register for the short courses and workshops you are interested in.

1) New solutions for TB management during and after the COVID-19 pandemic: Updated WHO TB recommendations


Date: Tuesday, 28 September 2021

Time: 13:00 to 16:00 CEST

Objectives of the course: The course will provide updates on the development, adoption and implementation of the WHO evidence-based recommendations on various aspects of prevention, screening, diagnosis, treatment and care of tuberculosis.

Session sponsor: World Health Organization, Global Tuberculosis Programme

Chairs: Dr Matteo Zignol (WHO) and Prof Charles Daley (National Jewish Health)


  • Dennis Falzon, WHO: Rapid access to TB guidance and implementation aids: the WHO TB Knowledge Sharing Platform & recommendation mapping
  • Cecily Miller, WHO; Avinash Kanchar, WHO: Updated recommendations on TB screening and prevention
  • Nazir Ismail, WHO; Fuad Mirzayev, WHO: Updated recommendations on TB diagnosis and treatment
  • Kerri Viney, WHO; Ernesto Jaramillo, WHO: Updated recommendations on the management of TB in children and adolescents and guidance on TB ethics and palliative care
  • Yana Terleeva, National Tuberculosis Control Program in Ukraine; Mike Frick, TAG: National TB programme and community perspectives on rapid adoption of new approaches to TB management

You can read a detailed description of the course here.


2) Systematic screening for TB at clinical settings: Don’t miss the TB patients at hand


Date: Tuesday, 5 October 2021

Time: 13:00 to 16:00 CEST

Objectives of the course: WHO has recently published consolidated guidelines on systematic TB screening for high-risk populations to increase TB case detection by active case finding (ACF). However, passive case finding at clinical settings is the greatest opportunity for TB diagnosis because patients with some sort of respiratory symptom and other outpatients like with diabetes are at high risk of TB.

In fact, 54% of bacteriologically confirmed TB cases identified by prevalence survey in Cambodia were not diagnosed as TB before the survey although they already had visited a medical facility due to some sort of respiratory symptom, probably because of lack of typical TB symptoms (subclinical TB), a low bacterial load in sputum, or a low sensitivity of a diagnostic tool.

This workshop aims to promote more active use of chest radiography (CXR) with a high sensitivity for systematic TB screening to accelerate TB detection at clinical settings.

Session sponsor: Japan Anti-Tuberculosis Association (JATA)

Chairs: Dr. Ikushi Onozaki, JATA; Bintari Dwihardiani, Center for Tropical Medicine, Faculty of Medicine, Public Health and Nursing, Gadjah Mada University

Coordinators: Kosuke Okada (JATA)


  • Seiya Kato, Research Institute of Tuberculosis (RIT)/Japan Anti-Tuberculosis Association (JATA): Roles of CXR mass-screening in TB control in Japan
  • Tieng Sivanna Deputy director of National Center for TB and Leprosy Control (CENAT): Downward trend in TB notification after nationwide DOTS decentralization in Cambodia
  • Bintari Dwihardiani, Zero TB Yogyakarta Project, Center for Tropical Medicine, Faculty of Medicine, Public Health, and Nursing, Gadjah Mada University, Yogyakarta, Indonesia: Country experience in Indonesia: opportunities and challenges in the use of CXR in ACF
  • Beatrice Frascella, Public Health Resident, Università Vita-Salute San Raffaele, Milano: Roles of CXR for detection of TB and subclinical TB
  • Kinz Eman, Director, Programmes from DOPASI Foundation, Islamabad, Pakistan: Performance of ultraportable CXR and CAD from the experience in the field

You can read a detailed description of the workshop here.


3) Joint GLI-GDI Workshop: Access to diagnostics, treatment, and care to end TB


Date: Thursday, 14 October 2021

Time: 14:00 to 17:00 CEST

TB detection, treatment and care of individuals with TB continue to be a challenge, particularly in settings with a high burden of disease and weakened healthcare infrastructure. More recently, the COVID-19 pandemic has added complex layers of stress to health systems worldwide, hampering progress in the fight against TB. The Global Laboratory Initiative (GLI) and the Global Drug- Resistant TB Initiative (GDI) are working towards strengthening laboratory and clinical management capacity for the programmatic management of TB. Through this workshop, we will explore the challenges encountered in countries, and steer the discussion on how to address these as protect progress in the fight against TB.

This workshop will implement a participatory learning approach through which attendees will partake in a plenary session and, through the use of breakout rooms, discuss case studies outlining countries' examples related to existing gaps and solutions to accelerate impact. Polling/quiz methods will also be implemented.

Session sponsor: World Health Organization, Global TB Programme

Chairs: Dr. Elisa Tagliani, San Raffaele Scientific Institute; Dr. Sarabjit Singh Chadha, The Foundation For Innovative New Diagnostics

Coordinators: Medea Gegia (WHO); Cal-Michael Nathanson (WHO)


  • Matteo Zigno, Who: WHO Guidelines on TB detection and DR-TB treatment: What is new and upcoming solutions
  • Patricia J. Hall, CDC: Selecting setting-specific solutions for TB detection: A New GLI Tool
  • Swapna Uplekar, FIND: Practical considerations for implementing next-generation sequencing in national TB programmes
  • Brian Citro, Stop TB: Legal and Policy Solutions to End DR-TB: An Assessment of 10 High-TB Burden Countries
  • Ignacio Monedero-Recuero, Global drug-resistant TB Initiative (GDI): Situation analysis of the ten high DR TB burden countries at two year from the UNHLM declaration: progress and setbacks in changing landscape

You can read a detailed description of the workshop here.